Acacia Pharma

company

About

Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.

  • Cambridge,Cambridgeshire,United Kingdom
  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active
Stock Symbol
epa:ACPH

Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$63.50M €40M
Acacia Pharma has raised a total of $63.50M €40M in funding over 2 rounds. Their latest funding was raised on Jul 2, 2018 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 2, 2018 Debt Financing $30M 1 Detail
Feb 21, 2018 IPO €40M Detail
Sep 3, 2013 Series B $23.50M 5 F-Prime Capital
Novo Holdings
Detail
Mar 31, 2011 Series A $10M 2 Lundbeckfonden Ventures Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Acacia Pharma has made 1 investments. Their most recent investment was on Jun 4, 2020, when Cosmo Pharmaceuticals raised $25M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Debt $25M Biotechnology

Investors

Number of Lead Investors
Number of Investors
3
6
Acacia Pharma is funded by 6 investors. F-Prime Capital and Novo Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
F-Prime Capital Yes Series B
Novo Holdings Yes Series B
Hercules Capital Debt Financing
Eight Roads Ventures Series B
Gilde Healthcare Series B
Lundbeckfonden Ventures Series B

Employee Profiles

Number of Employee Profiles
2
Acacia Pharma has 2 current employee profiles, including Board member Johan Kördel
Board member
Executive

Exits

Acacia Pharma has had 1 exits. Acacia Pharma most notable exits include Cosmo Pharmaceuticals

Date Company Name Exit Type Industry
Mar 23, 2007 Cosmo Pharmaceuticals IPO Biotechnology Detail